ArticleThe New England journal of medicine2019
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Young-Hak KimPubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled itcites it
ArticleThe New England journal of medicine2019
Young-Hak KimPubMed ↗Publisher ↗
No numbers read from the abstract.